NuvaRing Caused Deep Vein Thrombosis, Lawsuit Says
By Sarah Pierce
A North Carolina resident has filed a NuvaRing lawsuit against Organon USA, claiming the drug maker’s birth control product caused her to develop a severe blood clotting injury known as deep vein thrombosis (DVT) after only a few weeks of use. Her NuvaRing lawsuit claims Organon marketed, promoted and advertised NuvaRing as having a less dangerous risk of thrombotic side effects than oral birth control pills — all while knowing that it was actually more dangerous than the pill. Her case joins thousands of other NuvaRing blood clot lawsuits filed against Organon making similar allegations.The Plaintiff in the NuvaRing blood clot lawsuit, identified only as “Ms. Gatling,” alleges she used NuvaRing from June 20, 2010 to July 8, 2010 — the day she discovered she developed deep vein thrombosis. DVT is a blood clot in a deep vein, usually in the legs, that causes symptoms of pain, swelling, redness, warmness and engorged superficial veins in the leg. A DVT may go away with the help of blood-thinning medication, but it puts patients at risk for a life-threatening complication known as “pulmonary embolism,” in which the blood clot dislodges and travels to the lungs. Thousands of NuvaRing blood clot lawsuits have been filed by women seeking compensation after developing deep vein thrombosis and/or pulmonary embolism after using NuvaRing contraception.
Updated July 20th, 2012
{loadposition content_postads}
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
